Ambient AI Scribe
DeviceSoftware that records audio of a clinical interaction and generates a clinical note.
NCT Number: NCT07113938
The goal of this clinical trial is to assess the impacts of ambient AI scribes on the workload and burnout in physicians who see patients in a clinic setting at least twice in a week, as well as the impacts on patient-physician interaction.
The main questions it aims to answer are:
* What is the impact of ambient AI scribe use on physician workload and burnout? * What is the impact of ambient AI scribe use on quality of patient-physician interaction?
Researchers will compare the group of physicians using the ambient AI scribes to the group not using ambient AI scribes to see if there are any significant differences.
Participants randomly assigned to Group A will make use of the AI scribe and participants randomly assigned to Group B will not use any AI scribe for the 10 working day duration of the study. They will be asked to complete a survey assessing workload and burnout immediately prior to the commencement of the study and at the end of each week of the study or 5 full working days for part time physicians. They will also invite their patients to complete a survey assessing their experience after each clinical interaction.
Trial opening soon.
Get NotifiedAll sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Software that records audio of a clinical interaction and generates a clinical note.
Time frame: From enrolment to the end of the study at 10 working days.
The NASA-TLX is separated into six 100-point scales with 5-point steps that assess mental demand, physical demand, temporal demand, performance, effort, and frustration. A higher score indicates that they feel a greater degree of each of the domains.
Time frame: From enrolment to the end of the study at 10 working days.
The MBI-HSS (MP) is created specifically for medical personnel and assesses emotional exhaustion (9 items), depersonalization (5 items), and personal accomplishment (8 items).
Time frame: Throughout study completion at 10 working days.
The CARE measure consists of a series of 10 questions asked of patients with our focus on the domain of whether the physician was "really listening (paying close attention to what you were saying; not looking at the notes or computer as you were talking)" scored on a 5 point Likert scale.
Time frame: From enrollment to the completion of the study at 10 working days.
Documentation is scored by two blinded reviewers on a scale from 1-5 (with 5 indicating a higher quality) across 9 domains: up-to-date, accurate, thorough, useful, organized, comprehensible, succinct, synthesized, and internally consistent.
Time frame: From enrollment to the completion of the study at 10 working days.
The amount of time spent within the EMR for each clinical note and the amount of time spent editing the note on the ambient AI platform will be tracked using EMR logs and time-tracking tools.
Time frame: From enrollment to the completion of the study at 10 working days.
The amount of time spent using the EMR after regular working hours will be measured using EMR logs and time-tracking tools.
Contact information is provided by the study sponsor or research team.
Scott Adams, MD, PhD, MEd, FRCPC
CONTACT
Sundus Zia
CONTACT
University of Saskatchewan
Other
Assessing the Efficacy and Impact of Ambient AI Scribes in Healthcare: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07598721
Artificial Intelligence (AI), Behavior
Seattle, Washington, United States
View Trial DetailsNCT07542769
Behavior, Health Behavior
Chicago, Illinois, United States
View Trial DetailsNCT06969950
Behavior, Behavioral Symptoms
Providence, Rhode Island, United States
View Trial DetailsNCT05956470
Anxiety, Anxiety Disorders
Izmir, Balcova, Turkey (Türkiye)
View Trial Details